Portal de Periódicos da CAPES

Management of severe asthma: targeting the airways, comorbidities and risk factors

2017; Wiley; Volume: 47; Issue: 6 Linguagem: Inglês

10.1111/imj.13441

1445-5994

Peter G. Gibson, Vanessa M. McDonald,

Inhalation and Respiratory Drug Delivery

Severe asthma is a complex heterogeneous disease that is refractory to standard treatment and is complicated by multiple comorbidities and risk factors. In mild to moderate asthma, the burden of disease can be minimised by inhaled corticosteroids, bronchodilators and self‐management education. In severe asthma, however, management is more complex. When patients with asthma continue to experience symptoms and exacerbations despite optimal management, severe refractory asthma ( SRA ) should be suspected and confirmed, and other aetiologies ruled out. Once a diagnosis of SRA is established, patients should undergo a systematic and multidimensional assessment to identify inflammatory endotypes, risk factors and comorbidities, with targeted and individualised management initiated. We describe a practical approach to assessment and management of patients with SRA .